Search

Your search keyword '"Otsuka, Ayaka"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Otsuka, Ayaka" Remove constraint Author: "Otsuka, Ayaka"
26 results on '"Otsuka, Ayaka"'

Search Results

1. Comparison of Endoscopic and Microscopic Surgery for the Treatment of Acquired Cholesteatoma by EAONO/JOS Staging.

4. Supplementary Data from Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis

5. Supplementary Table from Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis

6. Data from Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis

7. Supplementary Figure from Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis

9. Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis

10. Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy

11. Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas

13. Deleterious Pulmonary Surfactant System Gene Mutations in Lung Adenocarcinomas Associated With Usual Interstitial Pneumonia

14. A Colonization Outbreak of Penicillin-Susceptible mecA-Positive Staphylococcus aureus in a Neonatal Ward of Children’s Hospital

15. Abstract 4264: Whole exome and targeted sequencing identified the MAPK and PI3K pathways as the main targets in intracranial and testicular germ cell tumors

19. Mutations and Deletions of the CBP Gene in Human Lung Cancer

21. Physical and Transcriptional Map of a 311-kb Segment of Chromosome 18q21, a Candidate Lung Tumor Suppressor Locus

25. WHOLE EXOME SEQUENCING IDENTIFIED THAT THE MAPK AND PI3K PATHWAYS ARE THE MAIN TARGETS FOR MUTATIONS IN INTRACRANIAL GERM CELL TUMORS.

26. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma.

Catalog

Books, media, physical & digital resources